Sonnet BioTherapeutic | 8-K: Current report

Feb 26 09:07 ET

Sonnet BioTherapeutic | 3: Initial statement of beneficial ownership of securities-Officer MCANDREW STEPHEN J

Feb 21 16:07 ET

Sonnet BioTherapeutic | 8-K: Current report

Feb 19 08:51 ET

Sonnet BioTherapeutic | 10-Q: Q1 2025 Earnings Report

Feb 13 16:22 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update

Feb 13 08:14 ET

Sonnet BioTherapeutic | EFFECT: Others

Feb 3 10:33 ET

Sonnet BioTherapeutic | EFFECT: Others

Feb 3 10:33 ET

Sonnet BioTherapeutic | 424B3: Prospectus

Jan 31 17:01 ET

Sonnet BioTherapeutic | 424B3: Prospectus

Jan 31 16:57 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 30 17:31 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 30 17:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Jan 28 09:14 ET

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

Jan 22 16:17 ET

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

Jan 22 16:13 ET

Sonnet BioTherapeutic | EFFECT: Others

Jan 22 06:03 ET

Sonnet BioTherapeutic | 8-K: Current report

Jan 21 09:21 ET

Sonnet BioTherapeutic | 424B3: Prospectus

Jan 21 08:31 ET

Sonnet BioTherapeutic | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Jan 13 16:37 ET

Sonnet BioTherapeutic | D: Filing D

Dec 23, 2024 16:06 ET

Sonnet BioTherapeutic | 10-K: FY2024 Annual Report

Dec 17, 2024 09:03 ET